CARRIE WATSON: Open Payments
NPI 1700513504 · MIDLAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$452 in 17 payments from 9 companies in 2025. Trend: 2023 $319 · 2024 $259 · 2025 $452
Food & beverage: $452
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 5 | $118 |
| AstraZeneca Pharmaceuticals LP | 2 | $105 |
| Otsuka America Pharmaceutical, Inc. | 2 | $65 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $52 |
| Lilly USA, LLC | 2 | $34 |
| Paratek Pharmaceuticals, Inc. | 1 | $21 |
| Inspire Medical Systems, Inc. | 1 | $20 |
| Novo Nordisk Inc | 1 | $20 |
| Esperion Therapeutics, Inc. | 1 | $18 |
Products named: GEMTESA, FARXIGA, REXULTI, CAPLYTA, MOUNJARO, NUZYRA, INSPIRE, Saxenda.
Industry payments across TX — which companies pay providers there.
